Current stock page

Financial Data

NEOG Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareMedical - DevicesScore data as of Nov 18, 2026

NEOGNeogen Corporation

Healthcare / Medical - Devices

Low Priority

Above Peers

NeutralEdge 7/10
$11.08+$0.18 (+1.65%)

Latest quote

  • Momentum
    74
  • Value
    49
  • Quality
    63
  • Risk resilience
    57
  • Sentiment
    —
algovestiq.comScore data as of Nov 18, 2026

Latest Quarter at a Glance

Quarter ended Aug 31, 2026, compared with the same quarter a year earlier.

Revenue
$222.8M
+6.5% YoY
Net income
-$11.9M
−132.7% YoY
Free cash flow
$4.7M
+135.7% YoY
Operating margin
-0.8%
+6.9 pts YoY

Quarterly Financial Statements

Updated Nov 19, 2026.

NEOG, last 8 quarters. YoY compares the latest quarter with the same quarter a year earlier.

Income statement
Income statement, last 8 quarters, newest first
MetricTrendYoYAug '26May '26Feb '26Nov '25Aug '25May '25Feb '25Nov '24
Revenue+6.5%$223M$225M$211M$225M$209M$225M$221M$231M
Gross profit+11.1%$106M$108M$99M$107M$95M$93M$87M$90M
Operating income+88.8%−$2M$3M−$3M−$5M−$16M−$13M$12M$17M
Net income−132.7%−$12M−$11M−$17M−$16M$36M−$612M−$11M−$456M
EPS (diluted)−129.4%−$0.05−$0.05−$0.08−$0.07$0.17−$2.82−$0.05−$2.10
Gross margin+2.0 pts47.4%47.8%46.9%47.5%45.4%41.2%39.4%38.8%
Operating margin+6.9 pts-0.8%1.4%-1.6%-2.4%-7.7%-5.9%5.4%7.4%
Net margin−22.7 pts-5.3%-5.0%-8.0%-7.1%17.4%-271.5%-5.0%-197.3%
Cash flow
Cash flow, last 8 quarters, newest first
MetricTrendYoYAug '26May '26Feb '26Nov '25Aug '25May '25Feb '25Nov '24
Operating cash flow+18.9%$13M$30M$23M$19M$11M$17M$19M$40M
Capital expenditure+65.8%−$8M−$4M−$12M−$12M−$24M−$16M−$33M−$17M
Free cash flow+135.7%$5M$26M$11M$8M−$13M$406K−$14M$23M
Free cash flow margin+8.4 pts2.1%11.6%5.2%3.5%-6.3%0.2%-6.1%10.0%
Balance sheet
Balance sheet, last 8 quarters, newest first
MetricTrendYoYAug '26May '26Feb '26Nov '25Aug '25May '25Feb '25Nov '24
Total assets−2.2%$3.30B$3.35B$3.36B$3.36B$3.38B$3.44B$4.04B$4.05B
Total liabilities−3.4%$1.22B$1.25B$1.26B$1.26B$1.26B$1.37B$1.38B$1.39B
Shareholders' equity−1.5%$2.09B$2.09B$2.10B$2.10B$2.12B$2.07B$2.66B$2.67B
Total debt−2.3%$774M$793M$793M$793M$793M$913M$893M$892M
Cash and equivalents+23.8%$172M$186M$160M$145M$139M$129M$128M$140M
Valuation and ratios
Valuation and ratios, last 8 quarters, newest first
MetricTrendYoYAug '26May '26Feb '26Nov '25Aug '25May '25Feb '25Nov '24
P/B ratio+0.531.221.201.041.000.690.490.410.92
Return on equity+46.5 pts-2.7%-0.4%-29.0%-28.6%-49.2%-52.7%-18.2%-17.8%
Debt to equity−0.000.370.380.380.380.370.440.340.33
Free cash flow yield+2.2 pts2.0%1.3%1.9%0.8%-0.2%-4.5%-4.1%-3.8%

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
MetricValue
P/E ratio-43.05x
P/B ratio1.14x
Revenue growth (YoY)6.51%
EPS growth (YoY)-129.41%
Gross margin47.40%
Operating margin-0.83%
ROE-2.68%
ROIC-0.19%
Debt to equity0.37
FCF yield2.09%

As of Nov 18, 2026

Technical indicators
MetricValue
Close
As of Nov 18, 2026
$11.08
Volume
As of Nov 13, 2026
1.8M
RSI (14)
As of Nov 13, 2026
40.09
MACD
As of Nov 13, 2026
-0.19
MACD signal
As of Nov 13, 2026
-0.11
MACD histogram
As of Nov 13, 2026
-0.08
ADX (14)
As of Nov 13, 2026
13.43
SMA (50)
As of Nov 13, 2026
$12.24
SMA (200)
As of Nov 13, 2026
$10.51
ATR (14)
As of Nov 13, 2026
$0.51
Historical volatility (annualized)
As of Nov 13, 2026
40.00%
Volume (20-day average)
As of Nov 13, 2026
2.98M
Risk measures
MetricValue
Resilience score57/100
Beta1.41
Annual volatility57.93%
Max drawdown-27.71%
Sharpe ratio1.19
VaR (95%, 1-day)-4.40%

As of Nov 18, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

NEOG Financial Data FAQ

What is Neogen Corporation's revenue?

Neogen Corporation's revenue is one of the core financial data points for NEOG. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is Neogen Corporation's revenue growing?

Revenue growth shows whether Neogen Corporation is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is NEOG's EPS?

NEOG's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is Neogen Corporation's net income?

Neogen Corporation's net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does Neogen Corporation generate?

Free cash flow shows how much cash Neogen Corporation generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does Neogen Corporation have?

Cash and debt help frame NEOG's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.